LCM
SAGE

Laurion Capital Management’s Sage Therapeutics SAGE Stock Holding History

Laurion Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,240
Closed -$1.49M – 879
2020
Q4 		$1.49M Buy
+17,240
New +$1.27M 0.01% 368
2020
Q2 		– Sell
-33,800
Closed -$971K – 1146
2020
Q1 		$971K Buy
+33,800
New +$1.96M 0.01% 488
2018
Q1 		– Sell
-35,052
Closed -$5.77M – 1643
2017
Q4 		$5.77M Buy
+35,052
New +$3.4M 0.03% 476
2016
Q4 		– Sell
-32,300
Closed -$1.49M – 1263
2016
Q3 		$1.49M Buy
+32,300
New +$1.31M 0.01% 523
2016
Q2 		– Sell
-9,500
Closed -$305K – 997
2016
Q1 		$305K Buy
+9,500
New +$334K ﹤0.01% 589

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return